Fig. 4From: Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjectsChange from baseline in FVC (mL) at week 52 in subjects in the SENSCIS trial versus matched hypothetical healthy references in subgroups by time since first non-Raynaud symptom. Reference subjects were matched to the SENSCIS subjects for age, sex, ethnicity and heightBack to article page